Comment on

• Effect of smoking reduction on later cessation: a pilot experimental study.

  Carpenter MJ, Hughes JR, Keely JP. Carpenter MJ, et al. Nicotine Tob Res. 2003 Apr;5(2):155-62. doi: 10.1080/146222003100007385. Nicotine Tob Res. 2003. PMID: 12745487 Clinical Trial.
• Discussion of NRT and other antismoking interventions in UK general practitioners' routine consultations.

  Coleman T, Wynn A, Barrett S, Wilson A. Coleman T, et al. Nicotine Tob Res. 2003 Apr;5(2):163-8. doi: 10.1080/1462220031000073261. Nicotine Tob Res. 2003. PMID: 12745488
• Effects of the nicotine patch on performance during the first week of smoking cessation.

  Cook MR, Gerkovich MM, Graham C, Hoffman SJ, Peterson RC. Cook MR, et al. Nicotine Tob Res. 2003 Apr;5(2):169-80. doi: 10.1080/1462220031000074873. Nicotine Tob Res. 2003. PMID: 12745489 Review.
• Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: a minimal intervention, randomized multicenter trial in a nonspecialized setting.

  Croghan GA, Sloan JA, Croghan IT, Novotny P, Hurt RD, DeKrey WL, Mailliard JA, Ebbert LP, Swan DK, Walsh DJ, Wiesenfeld M, Levitt R, Stella P, Johnson PA, Tschetter LK, Loprinzi C. Croghan GA, et al. Nicotine Tob Res. 2003 Apr;5(2):181-7. doi: 10.1080/1462220031000073252. Nicotine Tob Res. 2003. PMID: 12745490 Clinical Trial.
• Comparison of the effects of combined nicotine replacement therapy vs. cigarette smoking in males.

  Haustein KO, Krause J, Haustein H, Rasmussen T, Cort N. Haustein KO, et al. Nicotine Tob Res. 2003 Apr;5(2):195-203. doi: 10.1080/146222003100073676. Nicotine Tob Res. 2003. PMID: 12745492 Clinical Trial.
• Predictors of quitting in hospitalized smokers.

  Lando H, Hennrikus D, McCarty M, Vessey J. Lando H, et al. Nicotine Tob Res. 2003 Apr;5(2):215-22. doi: 10.1080/0955300031000083436. Nicotine Tob Res. 2003. PMID: 12745494 Clinical Trial.
• Efficacy of oral transmucosal nicotine lozenge for suppression of withdrawal symptoms in smoking abstinence.

  Muramoto ML, Ranger-Moore J, Leischow SJ. Muramoto ML, et al. Nicotine Tob Res. 2003 Apr;5(2):223-30. doi: 10.1080/1462220031000073270. Nicotine Tob Res. 2003. PMID: 12745495 Clinical Trial.
• Naltrexone treatment for alcoholics: effect on cigarette smoking rates.

  Rohsenow DJ, Monti PM, Colby SM, Gulliver SB, Swift RM, Abrams DB. Rohsenow DJ, et al. Nicotine Tob Res. 2003 Apr;5(2):231-6. doi: 10.1080/1462220031000073298. Nicotine Tob Res. 2003. PMID: 12745496 Clinical Trial.
• The demand for nicotine replacement therapies.

  Tauras JA, Chaloupka FJ. Tauras JA, et al. Nicotine Tob Res. 2003 Apr;5(2):237-43. doi: 10.1080/1462220031000073306. Nicotine Tob Res. 2003. PMID: 12745497
• The heritability of failed smoking cessation and nicotine withdrawal in twins who smoked and attempted to quit.

  Xian H, Scherrer JF, Madden PA, Lyons MJ, Tsuang M, True WR, Eisen SA. Xian H, et al. Nicotine Tob Res. 2003 Apr;5(2):245-54. Nicotine Tob Res. 2003. PMID: 12745498
• A factor analysis of the Fagerström Test for Nicotine Dependence (FTND).

  Radzius A, Gallo JJ, Epstein DH, Gorelick DA, Cadet JL, Uhl GE, Moolchan ET. Radzius A, et al. Nicotine Tob Res. 2003 Apr;5(2):255-40. doi: 10.1080/1462220031000073289. Nicotine Tob Res. 2003. PMID: 12745499